Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

What I do know is it seems that the odds for success are now such that we are looking blessed.

I'm not sure why you say that. The company's inability to sign a decent partnership makes me seriously question how we get to the finish line. I still haven't recovered from the AS deal.

The dilution machine fired up in a big way last quarter and it didn't seem to put a dent in our cash needs. I'm hoping our B-UC Phase 2a will be very inexpensive but even so....the share count will easily be over 400M this time next year without an infusion.

The last filing said we were in preparation for both a B-COVID phase 2 (who is paying for another expensive IV trial) and a B-UC phase 2.

There was no mention of Locust Walk or licensing negotiations with regard to B-OM in the filing when just earlier this year reengaging LW for B-OM licensing was PR'd.

We just keep shoving things through phase 2 hoping something sticks:

B-ABSSSI: phase 3 too expensive, no partner
B-UP: Garbage AS deal for $420K
B-OM: No further mention of PR'd negotiations. I assume the prospects were similarly dismal to the B-UP deal.
Kevtrin: ran out of money to continue phase 2 trials.
B-UC: Planning phase 2 in 2H 2020.
B-COVID: Phase 2 in preparation.

I'm hanging tight with what I have but I'm not sure how we get the money to come out the other side. The drugs have potential but I'm losing sight of how we make it to the finish line.

Go IPIX!